Last €0.23 EUR
Change Today -0.007 / -2.97%
Volume 300.3K
NTC On Other Exchanges
As of 11:38 AM 08/28/14 All times are local (Market data is delayed by at least 15 minutes).

natraceutical sa (NTC) Snapshot

Previous Close
Day High
Day Low
52 Week High
10/24/13 - €0.35
52 Week Low
09/30/13 - €0.21
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for NATRACEUTICAL SA (NTC)

Related News

No related news articles were found.

natraceutical sa (NTC) Related Businessweek News

No Related Businessweek News Found

natraceutical sa (NTC) Details

Natraceutical, S.A. manufactures and sells a range of nutritional products to pharmacies and drugstores in France. The company develops and markets nutritional supplements in the weight control, health, beauty, energy, and OTC segments. It primarily offers weight control products, such as Turbodraine, Calorilight, Minceur 24, and Turboslim; and health products, including Gélée Royale, Chondralgic, Mémorex, and Lixifor in the areas of anti-stress, joint pain, memory and concentration, fatigue or body’s defenses, night’s rest, and intestinal functions, as well as a range of products to alleviate the symptoms of menopause. The company also provides tonics and multivitamins comprising Vitalité 4G and Acerola for the recovery of energy tone and the improvement of male sexuality; and beauty products consisting of Expert Cheveux and Expert Hyaluronic covering skin- and hair-care formulations, antiwrinkles, moisturizers, and hair strengtheners. In addition, it offers five formulations with natural active ingredients extracted from organic farming for use in the circulation, weight control, body detoxification, and vitality; and OTC products, Dormicalm and Venaclar. The company also operates in Spain, Benelux, Austria, Portugal, the United Kingdom, and other countries. Natraceutical, S.A. was incorporated in 1993 and is headquartered in Barcelona, Spain. Natraceutical, S.A. is a subsidiary of Natra, SA.

Founded in 1993

natraceutical sa (NTC) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: €260.0K
Compensation as of Fiscal Year 2013.

natraceutical sa (NTC) Key Developments

Natraceutical SA, Annual General Meeting, Jun 29, 2014

Natraceutical SA, Annual General Meeting, Jun 29, 2014. Location: SH Valencia Palace Hote. Agenda: To consider financial results for the year ended December 31, 2013; to consider election and re-election of directors; to consider acquisition of treasury stock; to consider reappointment of the auditors; to consider directors remunerations; to consider delegation of powers for the development, documentation and enforcement of the agreements adopted by the General Shareholders' Meeting; to consider requests and questions; and to consider approval of the minutes of the General Meeting by any of the legally established procedures.

Natraceutical SA Presents at 10th Foro MedCap, May-27-2014

Natraceutical SA Presents at 10th Foro MedCap, May-27-2014 . Venue: Palacio de la Bolsa, Plaza de la Lealtad, 1, 28014 Madrid, Spain.

Natraceutical SA Announces Consolidated Earnings Results for the First Quarter of 2014

Natraceutical SA announced consolidated earnings results for the first quarter of 2014. For the quarter the company reported profit from operations of EUR 2,496,000 against EUR 2,814,000 a year ago. Profit before tax was EUR 2,519,000 against EUR 2,881,000 a year ago. Net result was EUR 2,519,000 against EUR 2,881,000 a year ago. EBITDA was EUR 261,000 against EUR 294,000 a year ago.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NTC:SM €0.23 EUR -0.007

NTC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Natra SA €1.72 EUR -0.01
View Industry Companies

Industry Analysis


Industry Average

Valuation NTC Industry Range
Price/Earnings 100.0x
Price/Sales 2.4x
Price/Book 0.9x
Price/Cash Flow 65.1x
TEV/Sales 2.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NATRACEUTICAL SA, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at